Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoarthritis, Knee | 56 | 2024 | 1248 | 6.640 |
Why?
|
Arthroplasty, Replacement, Knee | 32 | 2023 | 1378 | 2.600 |
Why?
|
Knee Joint | 22 | 2024 | 1656 | 2.060 |
Why?
|
Osteophyte | 4 | 2022 | 44 | 1.570 |
Why?
|
Knee Injuries | 6 | 2022 | 495 | 1.530 |
Why?
|
Arthralgia | 7 | 2021 | 459 | 1.180 |
Why?
|
Cartilage, Articular | 10 | 2024 | 1088 | 1.180 |
Why?
|
Synovitis | 6 | 2023 | 209 | 1.160 |
Why?
|
Arthroscopy | 13 | 2023 | 969 | 1.150 |
Why?
|
Physical Therapy Modalities | 5 | 2022 | 533 | 0.870 |
Why?
|
Musculoskeletal Diseases | 4 | 2024 | 598 | 0.860 |
Why?
|
Rheumatic Diseases | 3 | 2024 | 657 | 0.860 |
Why?
|
Workplace | 4 | 2024 | 873 | 0.850 |
Why?
|
Osteoarthritis | 5 | 2023 | 1051 | 0.770 |
Why?
|
Pain Measurement | 19 | 2024 | 3576 | 0.730 |
Why?
|
Arthrography | 1 | 2021 | 148 | 0.710 |
Why?
|
Pain, Postoperative | 8 | 2024 | 1768 | 0.670 |
Why?
|
First Aid | 1 | 2019 | 71 | 0.660 |
Why?
|
Exercise | 8 | 2019 | 5939 | 0.650 |
Why?
|
Competitive Behavior | 1 | 2019 | 77 | 0.640 |
Why?
|
Ownership | 1 | 2021 | 338 | 0.630 |
Why?
|
Running | 2 | 2020 | 488 | 0.600 |
Why?
|
Occupational Health | 5 | 2024 | 812 | 0.590 |
Why?
|
Bone Marrow Diseases | 2 | 2016 | 234 | 0.550 |
Why?
|
Bone Diseases | 4 | 2024 | 411 | 0.520 |
Why?
|
Recovery of Function | 9 | 2024 | 2971 | 0.510 |
Why?
|
Absenteeism | 1 | 2017 | 247 | 0.500 |
Why?
|
Actigraphy | 1 | 2019 | 526 | 0.470 |
Why?
|
Independent Living | 1 | 2019 | 583 | 0.460 |
Why?
|
Magnetic Resonance Imaging | 23 | 2024 | 36548 | 0.460 |
Why?
|
Health Promotion | 4 | 2021 | 2209 | 0.450 |
Why?
|
Tibia | 9 | 2024 | 1064 | 0.450 |
Why?
|
Translations | 1 | 2014 | 84 | 0.450 |
Why?
|
Multilingualism | 1 | 2014 | 88 | 0.420 |
Why?
|
Shoulder | 3 | 2023 | 299 | 0.400 |
Why?
|
Aged | 72 | 2024 | 171219 | 0.400 |
Why?
|
Pain | 11 | 2023 | 5090 | 0.390 |
Why?
|
Rotator Cuff | 7 | 2023 | 348 | 0.390 |
Why?
|
Femur | 6 | 2024 | 1309 | 0.390 |
Why?
|
Middle Aged | 80 | 2024 | 223083 | 0.380 |
Why?
|
Motivation | 4 | 2019 | 2019 | 0.360 |
Why?
|
Menisci, Tibial | 5 | 2022 | 266 | 0.360 |
Why?
|
Heat Stroke | 2 | 2021 | 29 | 0.360 |
Why?
|
Arm Injuries | 2 | 2022 | 156 | 0.350 |
Why?
|
Anterior Cruciate Ligament | 2 | 2015 | 423 | 0.350 |
Why?
|
Disease Progression | 16 | 2024 | 13616 | 0.340 |
Why?
|
Humans | 130 | 2024 | 766117 | 0.340 |
Why?
|
Weight Loss | 4 | 2023 | 2711 | 0.340 |
Why?
|
Carpal Tunnel Syndrome | 4 | 2019 | 305 | 0.330 |
Why?
|
Arthritis, Infectious | 3 | 2023 | 347 | 0.330 |
Why?
|
Range of Motion, Articular | 3 | 2016 | 1593 | 0.320 |
Why?
|
Arthroplasty, Replacement, Hip | 6 | 2019 | 1414 | 0.320 |
Why?
|
Male | 86 | 2024 | 363935 | 0.310 |
Why?
|
Health Status Indicators | 1 | 2014 | 968 | 0.310 |
Why?
|
Universities | 1 | 2014 | 1004 | 0.310 |
Why?
|
Nursing Homes | 4 | 2024 | 1084 | 0.300 |
Why?
|
Osteoporosis | 3 | 2022 | 1582 | 0.300 |
Why?
|
Female | 85 | 2024 | 396233 | 0.290 |
Why?
|
Prosthesis-Related Infections | 3 | 2023 | 497 | 0.290 |
Why?
|
Motor Activity | 2 | 2014 | 2711 | 0.280 |
Why?
|
Obesity, Morbid | 3 | 2023 | 1293 | 0.280 |
Why?
|
Shoulder Pain | 3 | 2023 | 152 | 0.270 |
Why?
|
Fractures, Stress | 2 | 2019 | 202 | 0.270 |
Why?
|
Upper Extremity | 4 | 2022 | 684 | 0.260 |
Why?
|
Patient Satisfaction | 6 | 2020 | 3477 | 0.260 |
Why?
|
Catastrophization | 3 | 2020 | 352 | 0.260 |
Why?
|
Preoperative Period | 5 | 2024 | 565 | 0.250 |
Why?
|
Orthopedic Procedures | 3 | 2024 | 1279 | 0.250 |
Why?
|
Resilience, Psychological | 2 | 2024 | 808 | 0.250 |
Why?
|
Knee Prosthesis | 3 | 2018 | 373 | 0.250 |
Why?
|
Obesity | 7 | 2023 | 13085 | 0.250 |
Why?
|
Quality-Adjusted Life Years | 6 | 2022 | 1740 | 0.240 |
Why?
|
Treatment Outcome | 29 | 2024 | 65219 | 0.230 |
Why?
|
Health Care Costs | 4 | 2024 | 3243 | 0.230 |
Why?
|
Gastric Bypass | 2 | 2023 | 820 | 0.230 |
Why?
|
Hot Temperature | 2 | 2021 | 1440 | 0.220 |
Why?
|
Radiography | 6 | 2017 | 6943 | 0.220 |
Why?
|
Medicare | 5 | 2024 | 6820 | 0.220 |
Why?
|
Chronic Disease | 1 | 2018 | 9354 | 0.220 |
Why?
|
Severity of Illness Index | 12 | 2021 | 15882 | 0.210 |
Why?
|
Shoulder Fractures | 1 | 2023 | 93 | 0.200 |
Why?
|
Exercise Therapy | 2 | 2020 | 938 | 0.200 |
Why?
|
Health Facilities, Proprietary | 1 | 2021 | 37 | 0.190 |
Why?
|
Cost-Benefit Analysis | 8 | 2023 | 5531 | 0.190 |
Why?
|
Time Factors | 11 | 2021 | 40108 | 0.190 |
Why?
|
Joint Diseases | 2 | 2018 | 459 | 0.190 |
Why?
|
Spinal Neoplasms | 2 | 2022 | 708 | 0.180 |
Why?
|
Psychological Tests | 1 | 2023 | 642 | 0.180 |
Why?
|
Predictive Value of Tests | 7 | 2021 | 15403 | 0.180 |
Why?
|
Disability Evaluation | 4 | 2024 | 1824 | 0.180 |
Why?
|
Cartilage Diseases | 1 | 2022 | 159 | 0.180 |
Why?
|
Fracture Healing | 1 | 2023 | 448 | 0.180 |
Why?
|
Humeral Fractures | 1 | 2023 | 283 | 0.170 |
Why?
|
Tibial Fractures | 1 | 2023 | 276 | 0.170 |
Why?
|
Adult | 38 | 2024 | 223139 | 0.170 |
Why?
|
Arthroplasty | 2 | 2020 | 305 | 0.170 |
Why?
|
Multivariate Analysis | 8 | 2017 | 12061 | 0.170 |
Why?
|
Longitudinal Studies | 6 | 2021 | 14747 | 0.170 |
Why?
|
Decompression, Surgical | 2 | 2017 | 602 | 0.170 |
Why?
|
Maine | 1 | 2019 | 146 | 0.170 |
Why?
|
Massachusetts | 6 | 2024 | 8882 | 0.160 |
Why?
|
Athletic Injuries | 2 | 2020 | 1244 | 0.160 |
Why?
|
Blister | 1 | 2019 | 88 | 0.160 |
Why?
|
Age Factors | 10 | 2021 | 18386 | 0.160 |
Why?
|
Analgesics, Opioid | 4 | 2023 | 3836 | 0.160 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2019 | 110 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 418 | 0.150 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2022 | 2156 | 0.150 |
Why?
|
Postoperative Care | 2 | 2016 | 1475 | 0.150 |
Why?
|
Social Conditions | 1 | 2019 | 118 | 0.150 |
Why?
|
Rheumatology | 1 | 2024 | 620 | 0.150 |
Why?
|
Weather | 1 | 2019 | 234 | 0.150 |
Why?
|
Ultrasonic Therapy | 1 | 2020 | 216 | 0.150 |
Why?
|
Median Nerve | 1 | 2019 | 131 | 0.150 |
Why?
|
Female Athlete Triad Syndrome | 1 | 2019 | 62 | 0.150 |
Why?
|
Electrodiagnosis | 1 | 2019 | 149 | 0.150 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 168 | 0.150 |
Why?
|
Cumulative Trauma Disorders | 1 | 2019 | 152 | 0.150 |
Why?
|
Patella | 2 | 2016 | 310 | 0.150 |
Why?
|
Organ Size | 3 | 2020 | 2260 | 0.140 |
Why?
|
Sex Factors | 8 | 2024 | 10614 | 0.140 |
Why?
|
Menstruation Disturbances | 1 | 2019 | 140 | 0.140 |
Why?
|
Cluster Analysis | 1 | 2024 | 2718 | 0.140 |
Why?
|
Models, Economic | 2 | 2019 | 716 | 0.140 |
Why?
|
United States | 18 | 2024 | 72920 | 0.140 |
Why?
|
Osteoporotic Fractures | 1 | 2022 | 415 | 0.140 |
Why?
|
Musculoskeletal System | 1 | 2019 | 187 | 0.140 |
Why?
|
Cubital Tunnel Syndrome | 1 | 2017 | 34 | 0.140 |
Why?
|
Leadership | 2 | 2024 | 1394 | 0.140 |
Why?
|
Moving and Lifting Patients | 1 | 2017 | 18 | 0.140 |
Why?
|
Caloric Restriction | 1 | 2019 | 303 | 0.140 |
Why?
|
Postoperative Period | 5 | 2020 | 1820 | 0.130 |
Why?
|
Tramadol | 1 | 2016 | 63 | 0.130 |
Why?
|
Cohort Studies | 14 | 2020 | 41684 | 0.130 |
Why?
|
Activities of Daily Living | 4 | 2021 | 2419 | 0.130 |
Why?
|
Incidence | 5 | 2019 | 21513 | 0.130 |
Why?
|
Acupuncture Therapy | 1 | 2020 | 467 | 0.130 |
Why?
|
Mental Health | 2 | 2024 | 3273 | 0.130 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.130 |
Why?
|
Neuralgia | 1 | 2022 | 627 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2020 | 744 | 0.130 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 357 | 0.120 |
Why?
|
Oxycodone | 1 | 2016 | 144 | 0.120 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 791 | 0.120 |
Why?
|
Dominican Republic | 4 | 2018 | 78 | 0.120 |
Why?
|
Edema | 1 | 2019 | 763 | 0.120 |
Why?
|
Orthopedics | 2 | 2014 | 901 | 0.120 |
Why?
|
AIDS Serodiagnosis | 2 | 2013 | 220 | 0.120 |
Why?
|
Case-Control Studies | 9 | 2023 | 22228 | 0.120 |
Why?
|
Dexamethasone | 2 | 2019 | 1962 | 0.120 |
Why?
|
Radius Fractures | 1 | 2020 | 515 | 0.120 |
Why?
|
Biomedical Research | 2 | 2024 | 3458 | 0.120 |
Why?
|
Proprioception | 1 | 2015 | 134 | 0.120 |
Why?
|
Retrospective Studies | 18 | 2024 | 81565 | 0.110 |
Why?
|
Program Evaluation | 3 | 2018 | 2502 | 0.110 |
Why?
|
Blood Glucose | 2 | 2019 | 6421 | 0.110 |
Why?
|
Patient Acceptance of Health Care | 3 | 2024 | 3230 | 0.110 |
Why?
|
Dietary Carbohydrates | 1 | 2019 | 896 | 0.110 |
Why?
|
Soft Tissue Injuries | 1 | 2015 | 173 | 0.110 |
Why?
|
Bone Marrow | 3 | 2024 | 2916 | 0.110 |
Why?
|
Bone Remodeling | 1 | 2017 | 577 | 0.110 |
Why?
|
Herpes Zoster | 1 | 2016 | 252 | 0.110 |
Why?
|
Self Report | 4 | 2024 | 3769 | 0.110 |
Why?
|
Refusal to Participate | 1 | 2013 | 30 | 0.100 |
Why?
|
Prosthesis Design | 2 | 2018 | 2111 | 0.100 |
Why?
|
Laser Therapy | 1 | 2020 | 1108 | 0.100 |
Why?
|
Hand | 1 | 2018 | 909 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1121 | 0.100 |
Why?
|
Developing Countries | 2 | 2017 | 2914 | 0.100 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1380 | 0.100 |
Why?
|
Ohio | 2 | 2024 | 320 | 0.100 |
Why?
|
Diabetes Complications | 1 | 2019 | 1318 | 0.100 |
Why?
|
Research Report | 1 | 2015 | 367 | 0.100 |
Why?
|
Allied Health Personnel | 1 | 2013 | 156 | 0.100 |
Why?
|
Tendinopathy | 1 | 2014 | 174 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2020 | 1393 | 0.090 |
Why?
|
Muscle Strength | 1 | 2016 | 638 | 0.090 |
Why?
|
Research Design | 3 | 2019 | 6206 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1204 | 0.090 |
Why?
|
Prospective Studies | 12 | 2024 | 54812 | 0.090 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2022 | 792 | 0.090 |
Why?
|
Laparoscopy | 1 | 2022 | 2040 | 0.090 |
Why?
|
Healthcare Disparities | 3 | 2024 | 3407 | 0.090 |
Why?
|
Cartilage | 1 | 2014 | 797 | 0.090 |
Why?
|
Body Mass Index | 5 | 2021 | 13046 | 0.090 |
Why?
|
Financing, Personal | 1 | 2013 | 310 | 0.090 |
Why?
|
Medicaid | 2 | 2022 | 2835 | 0.090 |
Why?
|
Boston | 6 | 2021 | 9335 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 2015 | 1194 | 0.090 |
Why?
|
Prognosis | 5 | 2023 | 29912 | 0.080 |
Why?
|
Quality of Life | 5 | 2021 | 13468 | 0.080 |
Why?
|
Fractures, Bone | 1 | 2022 | 2041 | 0.080 |
Why?
|
Reoperation | 5 | 2023 | 4309 | 0.080 |
Why?
|
Spinal Cord Compression | 1 | 2012 | 234 | 0.080 |
Why?
|
Logistic Models | 4 | 2017 | 13273 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59515 | 0.080 |
Why?
|
Bone Density | 2 | 2021 | 3491 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2013 | 993 | 0.080 |
Why?
|
X-Ray Microtomography | 2 | 2023 | 454 | 0.080 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26290 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2018 | 3561 | 0.080 |
Why?
|
Multicystic Dysplastic Kidney | 1 | 2008 | 7 | 0.080 |
Why?
|
Testicular Hydrocele | 1 | 2008 | 27 | 0.080 |
Why?
|
Registries | 2 | 2017 | 8347 | 0.080 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2014 | 453 | 0.080 |
Why?
|
Bone Plates | 2 | 2023 | 468 | 0.080 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39243 | 0.080 |
Why?
|
Postoperative Complications | 4 | 2021 | 15808 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2019 | 2894 | 0.070 |
Why?
|
Gastrectomy | 2 | 2023 | 693 | 0.070 |
Why?
|
Medical Records | 1 | 2013 | 1408 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2195 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2013 | 961 | 0.070 |
Why?
|
Health Surveys | 2 | 2014 | 4058 | 0.070 |
Why?
|
Synovial Fluid | 2 | 2023 | 386 | 0.070 |
Why?
|
Young Adult | 10 | 2024 | 59868 | 0.070 |
Why?
|
Hydroxychloroquine | 2 | 2022 | 429 | 0.070 |
Why?
|
Disabled Persons | 1 | 2016 | 1208 | 0.070 |
Why?
|
Weight-Bearing | 2 | 2024 | 530 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 1777 | 0.070 |
Why?
|
Comorbidity | 3 | 2020 | 10579 | 0.060 |
Why?
|
Aneuploidy | 1 | 2010 | 576 | 0.060 |
Why?
|
HIV | 1 | 2013 | 1587 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3743 | 0.060 |
Why?
|
Insurance, Health | 2 | 2020 | 2520 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14645 | 0.060 |
Why?
|
Rotation | 2 | 2018 | 513 | 0.060 |
Why?
|
Length of Stay | 1 | 2019 | 6490 | 0.060 |
Why?
|
Databases, Factual | 2 | 2017 | 8062 | 0.060 |
Why?
|
Congenital Abnormalities | 1 | 2010 | 704 | 0.060 |
Why?
|
Proteome | 1 | 2014 | 1896 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4249 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8230 | 0.060 |
Why?
|
Observer Variation | 3 | 2016 | 2611 | 0.060 |
Why?
|
Risk Factors | 8 | 2024 | 74857 | 0.060 |
Why?
|
Inflammation | 2 | 2023 | 10860 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2021 | 20137 | 0.060 |
Why?
|
Social Class | 1 | 2013 | 2007 | 0.050 |
Why?
|
Spinal Cord | 1 | 2012 | 1811 | 0.050 |
Why?
|
Computer Simulation | 4 | 2019 | 6254 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10380 | 0.050 |
Why?
|
Gentamicins | 1 | 2023 | 244 | 0.050 |
Why?
|
Hemodynamics | 1 | 2013 | 4188 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3360 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 1 | 2010 | 1772 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2008 | 1271 | 0.050 |
Why?
|
Linear Models | 3 | 2016 | 5873 | 0.050 |
Why?
|
Knee | 1 | 2023 | 273 | 0.050 |
Why?
|
Matrix Metalloproteinases | 1 | 2024 | 392 | 0.050 |
Why?
|
Polyethylenes | 1 | 2023 | 289 | 0.040 |
Why?
|
Reward | 2 | 2018 | 980 | 0.040 |
Why?
|
Proteomics | 1 | 2014 | 3907 | 0.040 |
Why?
|
Diet | 1 | 2019 | 8087 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2023 | 8113 | 0.040 |
Why?
|
Hypertrophy | 1 | 2022 | 562 | 0.040 |
Why?
|
Collagen Type I | 1 | 2024 | 616 | 0.040 |
Why?
|
Pregnancy-Associated alpha 2-Macroglobulins | 1 | 2019 | 6 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18321 | 0.040 |
Why?
|
Down Syndrome | 1 | 2008 | 915 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4859 | 0.040 |
Why?
|
California | 1 | 2024 | 1435 | 0.040 |
Why?
|
Insurance Claim Reporting | 1 | 2020 | 166 | 0.040 |
Why?
|
Odds Ratio | 3 | 2017 | 9657 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4736 | 0.040 |
Why?
|
Skilled Nursing Facilities | 1 | 2023 | 407 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2023 | 1605 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9082 | 0.040 |
Why?
|
Osteotomy | 1 | 2023 | 835 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14066 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1121 | 0.040 |
Why?
|
Preoperative Care | 2 | 2017 | 2249 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7424 | 0.040 |
Why?
|
Age Distribution | 2 | 2014 | 2865 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2018 | 2235 | 0.040 |
Why?
|
Rats | 2 | 2023 | 23717 | 0.040 |
Why?
|
Prevalence | 3 | 2019 | 15827 | 0.030 |
Why?
|
Sleep | 2 | 2023 | 4816 | 0.030 |
Why?
|
Adolescent | 6 | 2024 | 88819 | 0.030 |
Why?
|
Muscle Strength Dynamometer | 1 | 2016 | 41 | 0.030 |
Why?
|
Anesthesia, Spinal | 1 | 2019 | 280 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2782 | 0.030 |
Why?
|
Collagen | 1 | 2024 | 2617 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2017 | 5300 | 0.030 |
Why?
|
Hyperalgesia | 1 | 2019 | 531 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 507 | 0.030 |
Why?
|
Patients | 1 | 2022 | 908 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2021 | 1707 | 0.030 |
Why?
|
Herpesvirus 3, Human | 1 | 2016 | 159 | 0.030 |
Why?
|
Keratan Sulfate | 1 | 2014 | 17 | 0.030 |
Why?
|
Morphine | 1 | 2019 | 661 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1596 | 0.030 |
Why?
|
Clusterin | 1 | 2014 | 72 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2014 | 142 | 0.030 |
Why?
|
Patellofemoral Joint | 1 | 2016 | 133 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 713 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2019 | 1238 | 0.030 |
Why?
|
Africa | 1 | 2016 | 726 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2646 | 0.030 |
Why?
|
Anticipation, Psychological | 1 | 2014 | 90 | 0.030 |
Why?
|
Fracture Fixation, Internal | 1 | 2020 | 981 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16716 | 0.030 |
Why?
|
Prediabetic State | 1 | 2019 | 547 | 0.030 |
Why?
|
Hypertension | 1 | 2013 | 8616 | 0.030 |
Why?
|
Risk Assessment | 3 | 2021 | 24276 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1423 | 0.020 |
Why?
|
Lost to Follow-Up | 1 | 2013 | 124 | 0.020 |
Why?
|
Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
Analgesics | 1 | 2019 | 1067 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2024 | 3853 | 0.020 |
Why?
|
Wrist Joint | 1 | 2014 | 264 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2017 | 2915 | 0.020 |
Why?
|
Psychometrics | 1 | 2021 | 3060 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2936 | 0.020 |
Why?
|
Athletes | 1 | 2019 | 1162 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1394 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2020 | 1544 | 0.020 |
Why?
|
Models, Biological | 2 | 2020 | 9445 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1753 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1297 | 0.020 |
Why?
|
Medication Adherence | 1 | 2022 | 2190 | 0.020 |
Why?
|
Tendon Injuries | 1 | 2014 | 329 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2019 | 1389 | 0.020 |
Why?
|
Telephone | 1 | 2013 | 627 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2024 | 4544 | 0.020 |
Why?
|
Body Composition | 1 | 2019 | 2441 | 0.020 |
Why?
|
Joint Instability | 1 | 2016 | 802 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2555 | 0.020 |
Why?
|
Estriol | 1 | 2008 | 53 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2016 | 1225 | 0.020 |
Why?
|
Vitamin D | 1 | 2022 | 3272 | 0.020 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 83 | 0.020 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2008 | 59 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2469 | 0.020 |
Why?
|
Nuchal Translucency Measurement | 1 | 2008 | 59 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3614 | 0.020 |
Why?
|
Inhibins | 1 | 2008 | 210 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4626 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2008 | 227 | 0.020 |
Why?
|
Saliva | 1 | 2012 | 852 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2270 | 0.020 |
Why?
|
Shoulder Joint | 1 | 2014 | 740 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 2010 | 737 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2196 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 3138 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20700 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2694 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 17535 | 0.020 |
Why?
|
Animals | 3 | 2023 | 168800 | 0.020 |
Why?
|
HIV Antibodies | 1 | 2012 | 1337 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3955 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5988 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2010 | 917 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2510 | 0.020 |
Why?
|
Patient Preference | 1 | 2012 | 947 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8494 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7474 | 0.010 |
Why?
|
Walking | 1 | 2012 | 1198 | 0.010 |
Why?
|
Income | 1 | 2013 | 1874 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2689 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1949 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13400 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4338 | 0.010 |
Why?
|
Poverty | 1 | 2014 | 2714 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8724 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1937 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9599 | 0.010 |
Why?
|
Software | 1 | 2014 | 4463 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5889 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10811 | 0.010 |
Why?
|
Pregnancy | 2 | 2010 | 30233 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5450 | 0.010 |
Why?
|
Genetic Testing | 1 | 2010 | 3594 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12235 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7871 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4712 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 26381 | 0.000 |
Why?
|